Kexing Biopharm Co., Ltd. (SHA:688136)
China
· Delayed Price · Currency is CNY 30.64
+0.77 (2.58%)
Mar 10, 2026, 11:04 AM CST
Kexing Biopharm Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | - | 554.56 | 568.8 | 785.38 | 877.62 | Upgrade
|
| Cash & Short-Term Investments | 612.79 | 554.56 | 568.8 | 785.38 | 877.62 | Upgrade
|
| Cash Growth | 10.50% | -2.50% | -27.58% | -10.51% | -20.41% | Upgrade
|
| Accounts Receivable | - | 563.82 | 342.04 | 387.44 | 382.62 | Upgrade
|
| Other Receivables | - | 15.9 | 4.45 | 3.25 | 2.84 | Upgrade
|
| Receivables | - | 579.72 | 346.49 | 390.69 | 385.46 | Upgrade
|
| Inventory | - | 141.81 | 191.36 | 208.18 | 172.16 | Upgrade
|
| Other Current Assets | - | 11.72 | 26.97 | 27.06 | 25.57 | Upgrade
|
| Total Current Assets | - | 1,288 | 1,134 | 1,411 | 1,461 | Upgrade
|
| Property, Plant & Equipment | - | 1,177 | 1,200 | 1,053 | 936.24 | Upgrade
|
| Long-Term Investments | - | 203.41 | 245.32 | 15 | 247.46 | Upgrade
|
| Other Intangible Assets | - | 225.14 | 158.72 | 165.82 | 26.96 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | 0.31 | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | 117.22 | 133.98 | 80.83 | 12.1 | Upgrade
|
| Long-Term Deferred Charges | - | 50.37 | 3.08 | - | 21.82 | Upgrade
|
| Other Long-Term Assets | - | 101.02 | 156.61 | 438.91 | 123.64 | Upgrade
|
| Total Assets | - | 3,162 | 3,031 | 3,165 | 2,829 | Upgrade
|
| Accounts Payable | - | 71.91 | 56.02 | 67.78 | 65.73 | Upgrade
|
| Accrued Expenses | - | 112.98 | 84.14 | 92.89 | 97.63 | Upgrade
|
| Short-Term Debt | - | 269.12 | 120.7 | 162.69 | 276.26 | Upgrade
|
| Current Portion of Long-Term Debt | - | 313.25 | 275.03 | 51.78 | - | Upgrade
|
| Current Portion of Leases | - | 12.45 | 6.7 | 19.87 | 18.39 | Upgrade
|
| Current Unearned Revenue | - | 9.78 | 20.44 | 17.99 | 7.16 | Upgrade
|
| Other Current Liabilities | - | 96.91 | 106.97 | 126.36 | 138.44 | Upgrade
|
| Total Current Liabilities | - | 886.4 | 669.99 | 539.37 | 603.61 | Upgrade
|
| Long-Term Debt | - | 611.18 | 695.84 | 779.23 | 263.37 | Upgrade
|
| Long-Term Leases | - | 14.78 | 17.79 | 24.96 | 43.25 | Upgrade
|
| Long-Term Unearned Revenue | - | 3.15 | 5.32 | 0.75 | 0.99 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 7.48 | 11.36 | 14.55 | 7.12 | Upgrade
|
| Total Liabilities | - | 1,523 | 1,400 | 1,359 | 918.34 | Upgrade
|
| Common Stock | - | 199.64 | 199.2 | 198.7 | 198.7 | Upgrade
|
| Additional Paid-In Capital | - | 1,288 | 1,282 | 1,274 | 1,266 | Upgrade
|
| Retained Earnings | - | 176.78 | 145.3 | 335.59 | 445.76 | Upgrade
|
| Treasury Stock | - | -31.12 | - | - | - | Upgrade
|
| Comprehensive Income & Other | - | 1.11 | -0.01 | - | - | Upgrade
|
| Total Common Equity | 1,714 | 1,635 | 1,626 | 1,808 | 1,911 | Upgrade
|
| Minority Interest | - | 4.34 | 4.77 | -2.53 | - | Upgrade
|
| Shareholders' Equity | 1,716 | 1,639 | 1,631 | 1,806 | 1,911 | Upgrade
|
| Total Liabilities & Equity | - | 3,162 | 3,031 | 3,165 | 2,829 | Upgrade
|
| Total Debt | 1,398 | 1,221 | 1,116 | 1,039 | 601.27 | Upgrade
|
| Net Cash (Debt) | -785.28 | -666.22 | -547.26 | -253.16 | 276.35 | Upgrade
|
| Net Cash Growth | - | - | - | - | -64.88% | Upgrade
|
| Net Cash Per Share | -3.99 | -3.39 | -2.76 | -1.26 | 1.40 | Upgrade
|
| Filing Date Shares Outstanding | 191.31 | 197.76 | 199.2 | 198.7 | 198.7 | Upgrade
|
| Total Common Shares Outstanding | 198.11 | 197.76 | 199.2 | 198.7 | 198.7 | Upgrade
|
| Working Capital | - | 401.41 | 463.63 | 871.94 | 857.2 | Upgrade
|
| Book Value Per Share | 8.65 | 8.27 | 8.16 | 9.10 | 9.62 | Upgrade
|
| Tangible Book Value | 1,478 | 1,410 | 1,467 | 1,643 | 1,884 | Upgrade
|
| Tangible Book Value Per Share | 7.46 | 7.13 | 7.37 | 8.27 | 9.48 | Upgrade
|
| Buildings | - | 754.25 | 662.95 | 609.2 | 361.78 | Upgrade
|
| Machinery | - | 514.22 | 370.42 | 326.3 | 243.82 | Upgrade
|
| Construction In Progress | - | 176.82 | 372.56 | 256.57 | 428.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.